Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02877
Species: Homo sapiens
Position : chr20:48400000-49200000
Year: 2024
Title: Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast cancer
PMID:  39277592
MONDO: MONDO:0007254
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MDA-MB-157
CVCL ID: CVCL_0618
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Chromatin interaction assay; Enhancer activity profiling
High Throughput Method: SMC1 HiChIP; H3K27ac ChIP-seq; RNA-seq
Low Throughput Method: RT-qPCR
About Target Gene
Target gene : CEBPB
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 12 found
Enhancer ID Position Tissue Cell Disease
E_02876 chr20:48400000-49200000 breast malignant cell breast cancer
E_01098 chr20:48900221-48901229 liver hepatoblast hepatocellular carcinoma
E_01105 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01106 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01107 chr20:48900221-48901229 liver malignant cell hepatocellular carcinoma
E_01108 chr20:48900221-48901229 liver hepatocyte hepatocellular carcinoma
E_01115 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01116 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01143 chr20:48900221-48901229 uterine cervix NA hepatocellular carcinoma
E_01145 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_02830 chr20:48915257-48915803 breast malignant cell breast cancer
E_00953 chr20:48997377-49019434 liver hepatocyte hepatocellular carcinoma
Expression of Target Genes for the Enhancer